Literature DB >> 9821568

Psychophysiologic responsivity in posttraumatic stress disorder: generalized hyperresponsiveness versus trauma specificity.

J H Casada1, R Amdur, R Larsen, I Liberzon.   

Abstract

BACKGROUND: Clinically, subjects with posttraumatic stress disorder (PTSD) are viewed as hyperresponsive to a variety of stimuli. Psychophysiologic studies, however, have demonstrated hyperresponsiveness only to stimuli that are closely related to the original trauma.
METHODS: This set of experiments uses a variety of stimuli that vary in trauma-relatedness, arousal level, sensory modality stimulated, and degree of cognitive processing demanded to assess the extent of generalization of physiologic responses. Heart rate (HR), frontal electromyogram (EMG), and skin conductance (EDG) responses were measured during presentation of each stimulus.
RESULTS: PTSD subjects (n = 15) had an elevated baseline EDG and increased HR and EMG responses to the trauma-related stimulus (combat sounds) compared to normal control subjects (n = 11) and combat control subjects (n = 10). No significant differences were noted between PTSD and control groups in response to non-trauma-related arousing stimuli.
CONCLUSIONS: These results suggest that the physiologic hyperresponsivity of PTSD subjects is limited to stimuli closely associated with the inciting trauma.

Entities:  

Mesh:

Year:  1998        PMID: 9821568     DOI: 10.1016/s0006-3223(98)00182-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  15 in total

Review 1.  Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management.

Authors:  Michael J Maher; Simon A Rego; Gregory M Asnis
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Skin conductance reactivity and respiratory sinus arrhythmia among maltreated and comparison youth: relations with aggressive behavior.

Authors:  Elana B Gordis; Nashla Feres; Christy L Olezeski; Ari N Rabkin; Penelope K Trickett
Journal:  J Pediatr Psychol       Date:  2009-12-07

3.  Individual variation in the propensity to attribute incentive salience to an appetitive cue predicts the propensity to attribute motivational salience to an aversive cue.

Authors:  Jonathan D Morrow; Stephen Maren; Terry E Robinson
Journal:  Behav Brain Res       Date:  2011-02-21       Impact factor: 3.332

4.  Expressive inhibition in response to stress: implications for emotional processing following trauma.

Authors:  Joshua D Clapp; Samantha C Patton; J Gayle Beck
Journal:  J Anxiety Disord       Date:  2014-12-05

5.  Information Processing Bias in Post-traumatic Stress Disorder.

Authors:  Darren L Weber
Journal:  Open Neuroimag J       Date:  2008-06-10

6.  Acute episodes of predator exposure in conjunction with chronic social instability as an animal model of post-traumatic stress disorder.

Authors:  Phillip R Zoladz; Cheryl D Conrad; Monika Fleshner; David M Diamond
Journal:  Stress       Date:  2008-07       Impact factor: 3.493

7.  Sign-tracking to an appetitive cue predicts incubation of conditioned fear in rats.

Authors:  Jonathan D Morrow; Benjamin T Saunders; Stephen Maren; Terry E Robinson
Journal:  Behav Brain Res       Date:  2014-04-18       Impact factor: 3.332

Review 8.  Targeting memory processes with drugs to prevent or cure PTSD.

Authors:  Christopher K Cain; George D Maynard; John H Kehne
Journal:  Expert Opin Investig Drugs       Date:  2012-07-27       Impact factor: 6.206

9.  Attentional Bias to Drug- and Stress-Related Pictorial Cues in Cocaine Addiction Comorbid with PTSD.

Authors:  Estate Sokhadze; Shraddha Singh; Christopher Stewart; Michael Hollifield; Ayman El-Baz; Allan Tasman
Journal:  J Neurother       Date:  2008-12-01

10.  Enhanced sensitivity to stress and drug/alcohol craving in abstinent cocaine-dependent individuals compared to social drinkers.

Authors:  Helen C Fox; Kwang-Ik A Hong; Kristen Siedlarz; Rajita Sinha
Journal:  Neuropsychopharmacology       Date:  2007-06-13       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.